ACTRN12618001552279已完成1 期
Radionuclide therapy using 177Lu-PSMA: a pilot study in men with castrate-resistant prostate cancer (LuPSMA trial)
St Vincent's Hospital0 个研究点目标入组 15 人开始时间: 2018年9月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
An early phase clinical trial evaluating the effectiveness of treatment of 177Lu-PSMA with idronoxil in men with castrate-resistant prostate cancer (LuPin Trial)ACTRN12618001073291St Vincent's Hospital Sydney56
尚未招募
2 期
A study to evaluate new treatment for prostate cancer with a type of radiation therapy with radionuclide - Lu psma and to compare with the standard treatment with Abiratetone.CTRI/2020/10/028341Tata Memorial Hospital
进行中（未招募）
2 期
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsProstatic DiseaseProstate CancerProstatic NeoplasmsNCT05150236Australian and New Zealand Urogenital and Prostate Cancer Trials Group93
招募中
2 期
177Lu-PSMA RADIOLIGAND THERAPY IN PATIENTS WITH LYMPH NODE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER UNDERGOING ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTIOprostate cancerNL-OMON52075Vrije Universiteit Medisch Centrum10
招募中
1 期
177Lu-PSMA RADIOLIGAND THERAPY IN PATIENTS WITH LYMPH NODE METASTATIC HORMONE-SENSITIVE PROSTATE CANCER UNDERGOING ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTIOprostate cancer, eligible for radical prostatectomy and extended pelvic lymph node dissection, with 1-3 pelvic nodal metastases on preoperative PSMA PETEUCTR2020-004991-16-NL10